Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin X Chen

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Progress in Medicinal Chemistry|September 22, 2010
The Journey to the Discovery of Boceprevir: an NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis CKevin X Chen, F George Njoroge
Current Opinion in Investigational Drugs (London, England : 2000)|August 4, 2009
A review of HCV protease inhibitorsKevin X Chen, F George Njoroge
Genome Biology|March 3, 2023
Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiationRyan M Boileau, Kevin X Chen, Robert Blelloch
Biorxiv : the Preprint Server for Biology|March 27, 2026
KMT2C and KMT2D amplify GRHL2-driven enhancer activationRyan M Boileau, Kevin X Chen, Robert Blelloch
Accounts of Chemical Research|January 16, 2008
Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infectionF George Njoroge, Kevin X Chen, Neng-Yang Shih, et al.
The Journal of Organic Chemistry|May 25, 2002
Novel dipeptide macrocycles from 4-oxo, -thio, and -amino-substituted proline derivativesAshok Arasappan, Kevin X Chen, F George Njoroge, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2005
Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 proteaseKevin X Chen, F George Njoroge, Andrew Prongay, et al.
The Journal of Organic Chemistry|April 13, 2002
Syntheses of novel 4-tert-alkyl ether proline-based 16- and 17-membered macrocyclic compoundsKevin X Chen, F George Njoroge, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry|September 30, 2005
Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine proteaseKevin X Chen, F George Njoroge, John Pichardo, et al.
Journal of Medicinal Chemistry|January 20, 2006
Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 proteaseKevin X Chen, F George Njoroge, John Pichardo, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Progress in Medicinal Chemistry|September 22, 2010
The Journey to the Discovery of Boceprevir: an NS3-NS4 HCV protease inhibitor for the treatment of chronic hepatitis CKevin X Chen, F George Njoroge
Current Opinion in Investigational Drugs (London, England : 2000)|August 4, 2009
A review of HCV protease inhibitorsKevin X Chen, F George Njoroge
Genome Biology|March 3, 2023
Loss of MLL3/4 decouples enhancer H3K4 monomethylation, H3K27 acetylation, and gene activation during embryonic stem cell differentiationRyan M Boileau, Kevin X Chen, Robert Blelloch
Biorxiv : the Preprint Server for Biology|March 27, 2026
KMT2C and KMT2D amplify GRHL2-driven enhancer activationRyan M Boileau, Kevin X Chen, Robert Blelloch
Accounts of Chemical Research|January 16, 2008
Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infectionF George Njoroge, Kevin X Chen, Neng-Yang Shih, et al.
The Journal of Organic Chemistry|May 25, 2002
Novel dipeptide macrocycles from 4-oxo, -thio, and -amino-substituted proline derivativesAshok Arasappan, Kevin X Chen, F George Njoroge, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2005
Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 proteaseKevin X Chen, F George Njoroge, Andrew Prongay, et al.
The Journal of Organic Chemistry|April 13, 2002
Syntheses of novel 4-tert-alkyl ether proline-based 16- and 17-membered macrocyclic compoundsKevin X Chen, F George Njoroge, Bancha Vibulbhan, et al.
Journal of Medicinal Chemistry|September 30, 2005
Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine proteaseKevin X Chen, F George Njoroge, John Pichardo, et al.
Journal of Medicinal Chemistry|January 20, 2006
Potent 7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid-based macrocyclic inhibitors of hepatitis C virus NS3 proteaseKevin X Chen, F George Njoroge, John Pichardo, et al.
Pageof 4